CD40 expression is accompanied by CD8 T cell infiltration in renal cell carcinoma, indicating that it may be useful as a biomarker for patient survival (Weiss et al., 2014). This evidence concerns the gene CD8A and hereditary clear cell renal cell carcinoma.